Nexalin Technology, Inc.
$0.47
▼
-0.73%
2026-04-21 08:33:01
www.nexalin.com
NCM: NXL
Explore Nexalin Technology, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$9.54 M
Current Price
$0.47
52W High / Low
$2 / $0.33
Stock P/E
—
Book Value
$0.2
Dividend Yield
—
ROCE
-223.88%
ROE
-2.22%
Face Value
—
EPS
$-0.5
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
—
Beta
4.23
Debt / Equity
—
Current Ratio
4.84
Quick Ratio
4.7
Forward P/E
-1.3
Price / Sales
27.42
Enterprise Value
$4.55 M
EV / EBITDA
-0.54
EV / Revenue
15.07
Rating
Buy
Target Price
$2
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Inogen, Inc. | $6.95 | — | $185.18 M | — | -12.85% | -12.43% | $9.13 / $5.34 | $7.06 |
| 2. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
| 3. | Hyperfine, Inc. | $1.29 | — | $128.32 M | — | -85.19% | -79.01% | $2.22 / $0.53 | $0.42 |
| 4. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 5. | Intelligent Bio Solutions Inc. | $2.93 | — | $5.86 M | — | -359.62% | -1.5% | $24.9 / $2.42 | $8.96 |
| 6. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 7. | GE HealthCare Technologies Inc. | $71.58 | 15.76 | $32.85 B | 0.19% | 9.93% | 22.38% | $89.77 / $59.95 | $22.77 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.17 M | 0.02 M | 0.07 M | 0.04 M | 0.03 M | — |
| Operating Profit | -2.41 M | -2.35 M | -1.62 M | -2.01 M | -2.88 M | — |
| Net Profit | -2.38 M | -2.28 M | -1.58 M | -1.99 M | -2.83 M | — |
| EPS in Rs | -0.12 | -0.11 | -0.08 | -0.1 | -0.14 | -0.23 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.3 M | 0.17 M | 0.11 M | 1.32 M |
| Operating Profit | -8.39 M | -7.75 M | -5.7 M | -1.83 M |
| Net Profit | -8.22 M | -7.61 M | -4.65 M | -1.7 M |
| EPS in Rs | -0.4 | -0.37 | -0.23 | -0.08 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 4.64 M | 4.22 M | 3.63 M | 7.43 M |
| Total Liabilities | 0.89 M | 0.55 M | 0.43 M | 1.95 M |
| Equity | 3.75 M | 3.68 M | 3.21 M | 5.48 M |
| Current Assets | 4.3 M | 3.96 M | 3.43 M | 7.43 M |
| Current Liabilities | 0.89 M | 0.55 M | 0.43 M | 1.95 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -4.96 M | -3.94 M | -3.84 M | -2.22 M |
| Investing CF | -0.13 M | -0.58 M | 4.45 M | -6.79 M |
| Financing CF | 5.17 M | 4.52 M | -0.2 M | 8.51 M |
| Free CF | -5.05 M | -4.11 M | -3.94 M | -2.22 M |
| Capex | -0.1 M | -0.17 M | -0.11 M | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 52.35% | -91.62% | — | — |
| Earnings Growth % | -63.64% | -173.81% | — | — |
| Profit Margin % | -4508.73% | -4197.56% | -128.49% | — |
| Operating Margin % | -4596.14% | -5143.48% | -138.72% | — |
| Gross Margin % | 78.31% | 76.8% | 72.51% | — |
| EBITDA Margin % | -4587.18% | -5139.63% | -138.68% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.